Trump Taps a ‘MAHA' Movement Leader for Surgeon General
Health Secretary Robert F. Kennedy Jr. in the Oval Office with President Trump earlier this week.
Photo: Jim Lo Scalzo/Bloomberg News
WASHINGTON—President Trump said he would nominate Dr. Casey Means , a California doctor and wellness influencer, to be the next surgeon general.
Means has become more prominent with the rise of Health Secretary Robert F. Kennedy Jr.'s 'Make America Healthy Again' movement. She and her brother, Kennedy adviser Calley Means, wrote a book, 'Good Energy,' that became popular with Trump campaign staffers and later with Kennedy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
36 minutes ago
- Entrepreneur
The Power of Love in Action: A Portrait of Transformational Work That Heals and Empowers
With a presence that's more powerful than performance, Dr. Fang Miao is guiding women through emotional healing, personal safety, and true transformation. Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media. She greets the world not with noise, but with quiet strength. In a time when fast advice and fleeting trends dominate, Dr. Fang Miao offers something rare: depth, presence, and transformation that lasts. A celebrated Women's Life Coach, educator, and social advocate, Dr. Miao has spent over two decades helping women not only find themselves—but truly return to themselves. As the President of the Association for the Protection of Asian Women in America, she has become a guiding force behind a movement that empowers from the inside out. Her recent book, Love to the Extreme: A Miracle Unfolds, is not just a publication—it's a map for the soul, inviting readers into a journey of awakening, emotional healing, and inner freedom. Dr. Miao's leadership transcends accolades—though her honors include the Stevie Award for Thought Leadership and a "Woman of the Year" nomination. What truly defines her impact is the quiet transformation of countless lives: women who have turned trauma into strength, confusion into clarity, and survival into soulful success. Elegant in prose yet grounded in real-life transformation, her latest work is not a philosophical musing—it is a field guide to deep, inner renewal. Rooted in nearly 20 years of coaching and experiential practice, the book distills personal transformation into a structured, three-phase process: cultivating self-awareness, deconstructing limiting beliefs, and realigning one's inner energy. "Fate is meant to be rewritten. What truly defines your destiny is not the moment you were born, but the moment you awaken to who you truly are." Drawing on techniques from family constellation, mind-body integration, and energy psychology, the book guides readers along a path that is both personal and universal. With case studies involving loss, anxiety, financial hardship, and healing, Love to the Extreme resonates not as distant theory, but as a roadmap for everyday miracles. Readers describe breakthroughs in relationships, renewed joy in parenting, emotional peace, and renewed career vitality. At its core, the book serves a dual purpose: a compassionate mirror and a practical method. It invites readers to shift their vibration—from contraction to expansion, from surviving to soulfully thriving. Beyond the book, Dr. Miao's vision comes alive through her community-based programs like the Women's Wellness & Fulfillment Retreat and Safe & Confident Living workshop series. These initiatives equip women with emotional regulation tools, personal safety skills, and inner strength—essentials for navigating a complex world. Her leadership has brought these programs to diverse communities, promoting well-being, self-worth, and safety. What sets Dr. Miao apart is her seamless integration of intellect and intuition. Drawing on neuroscience, trauma recovery, and spiritual insight, her teachings are both rigorous and deeply humane. Her philanthropic reach extends to underserved families and survivors of violence, providing practical support and hope. Love to the Extreme is not simply a book—it is an invitation to reimagine what's possible. For those ready to challenge internal limitations and step into clarity and boundless love, Dr. Miao offers not only mentorship, but a new way of being. In a world grappling with disconnection and uncertainty, her message is both balm and catalyst: healing is not a luxury—it is our natural state, waiting to be remembered. Her work offers more than inspiration—it provides a pathway to a more conscious, compassionate, and empowered world.
CBS News
an hour ago
- CBS News
Baltimore judge proposes slashing city's $266 million opioid verdict or new trial
A Baltimore judge on Thursday proposed reducing the city's $266 million settlement from a verdict against two drug distributors, suggesting that the companies pay just under $52 million or receive a new trial to determine damages. In a 96-page ruling, Baltimore City Circuit Judge Lawrence Fletcher-Hill agreed with the companies, McKesson and AmerisourceBergen, that the jury's award was too high and that jurors attributed too much blame to the companies for the opioid crisis. "This decision is disappointing to say the least. We are evaluating the decision and considering all of our options," Scott said in a statement. "While the court acknowledged that the City proved that McKesson and AmerisourceBergen were liable for the City's opioid crisis, we are disappointed that the court abandoned the remainder of the findings of the jury, which carefully reviewed this case over nearly two months last year." Baltimore City awarded millions after litigation with pharmaceutical companies The city began litigation against pharmaceutical manufacturers and distributors for their role in the opioid epidemic in 2018, opting out of a global settlement in order to pursue more restitution money. Public health experts said that the crisis began because of the availability of prescription opioids, which led residents to turn to illicit drugs. Throughout 2024, the city reached settlements with several large companies including Allergan, CVS, Teva, Cardinal Health, and Walgreens, bringing total recoveries to $402.5 million by September 2024. In Nov. 2024, a Baltimore jury found McKesson and AmerisourceBergen liable in Baltimore's opioid epidemic and awarded the City of Baltimore more than $266 million in damages. A month later, the city began working with the Board of Estimates and City Council to come up with a plan for using the restitution funds. The plan included administrative and oversight costs, funding for health department and recovery programs, community engagement, and planning for the replacement of the Druid Health Clinic. Opioid crisis in Baltimore A June 2024 report published by the Baltimore Banner and New York Times found that the death toll from opioid deaths among residents reached more than 6,000 over the past six years – more than double that of any other large U.S. city. The report also found that the opioid crisis in Baltimore disproportionately impacted Black residents, particularly those aged 55 to 70. Then, community members accused the city of failing to prioritize the needs of Black communities affected by the opioid epidemic.
Medscape
an hour ago
- Medscape
Daytime Sleepiness Tied to Risk for Early Death in Women
SEATTLE — Excessive daytime sleepiness (EDS) was associated with a significantly increased risk for all-cause mortality in women, results of a large observational study showed. After adjusting for health and demographic factors, women aged 50 and 65 years with high scores on the Epworth Sleepiness Scale (ESS) were 16% more likely to die from any cause than their counterparts who had normal levels of sleepiness on this tool. This association was not found in younger women or in those over age 65 years. 'Identifying middle age as a critical period suggests clinicians should prioritize an Epworth Sleepiness Scale assessment and excessive daytime sleepiness management in women approaching their 50s and early 60s,' lead author Arash Maghsoudi, PhD, with Baylor College of Medicine in Houston, said in a news release. The findings were presented on June 9 at SLEEP 2025. Data Gap in Women EDS has been associated with all-cause mortality in previous studies, which primarily focused on men. Maghsoudi and colleagues analyzed the medical records of 40,250 female veterans (mean age, 48 years) from 1999 to 2022, focusing on individuals with sleep-related International Classification of Diseases, 9th/10th Revision codes, or those who had received clinical sleep services. They used a validated natural language processing tool to extract ESS scores from clinical notes, with scores categorized as normal (0-10) or high (11-24). Participants were further stratified into three age groups: Young (< 50 years), middle-aged (≥ 50 to < 65 years), and older adults (≥ 65 years). The results were adjusted for age, race, ethnicity, BMI, and Charlson Comorbidity Index. In the overall cohort, the adjusted odds ratio for all-cause mortality in those with high ESS scores compared to those with normal ESS scores was not statistically significant. However, when stratified by age, middle-aged women with high ESS scores had a significantly higher likelihood of all-cause mortality (adjusted odds ratio, 1.16), with no significant associations seen in the younger or older age groups. The researchers said further studies are needed to explore potential mechanisms, including sex-specific responses to sleepiness and the role of age in this association. 'Intriguing' Data Commenting on this research for Medscape Medical News , Indira Gurubhagavatula, MD, MPH, director of the Sleep Medicine Fellowship and professor of medicine at the University of Pennsylvania Perelman School of Medicine in Philadelphia, said the finding that subjectively reported EDS in middle-aged women is associated with mortality strengthens the American Academy of Sleep Medicine (AASM) position that 'sleepiness matters.' The AASM recently published a position statement highlighting how sleepiness can interfere with daily functioning and serve as a marker for other conditions such as mental health problems, sleep disorders, or side effects of medications, as previously reported by Medscape Medical News . 'For these reasons, it is important for clinicians to ask their patients about sleepiness,' said Gurubhagavatula, a spokesperson for AASM. 'The Epworth Sleepiness Scale is a method to get quick, subjective responses and can help guide next steps in clinical evaluation. Improving sleepiness by treating the underlying cause can help restore daytime functioning at home and work, reduce risks of chronic health conditions, and improve people's quality of life,' Gurubhagavatula said. She noted that mechanistic reasons for the relationship between sleepiness and mortality in middle-aged women remain unknown. 'We need more studies to investigate the causal factors that would explain why this association exists,' she added. That said, 'the adjusted odds ratio is just above 1 (average 1.16) in the middle age group. If this is confirmed to be true, even though the risk seems small at an individual level, when you consider it across an entire population, the risk burden to society may be significant,' Gurubhagavatula told Medscape Medical News . She also cautioned that the study involved women veterans, whose risks for sleepiness and mortality may be different than those in other populations. Moreover, the results may not necessarily generalize to other groups. 'The bottom line is that the report is intriguing and calls for more studies to confirm this finding and help explain the mechanism,' Gurubhagavatula concluded.
